inflix | 13672

Infliximab (Remicade®), level and antibodies

Material
Serum
Serum gel tube, golden (1)
Min. quantity 1 mL
Stability 4 weeks / 2-8°C; 1 year / -20°C
Duration 1 - 2 weeks
Frequency 1 x per week
Method Enzyme Linked Immuno Sorbent Assay (ELISA)
Price CHF 127.80
Tariff 127.80 TP
Designation see single analyses

Single analyses

Infliximab (Remicade®), Spiegel
inflsp Serum, Serum für Medikamente, Plasma EDTA
inflsp Serum, Serum für Medikamente, Plasma EDTA
Infliximab (Remicade®), Antikörper
inflak Serum, Serum für Medikamente, Plasma EDTA
inflak Serum, Serum für Medikamente, Plasma EDTA

Team of consultants

Dr. sc. nat. ETH, FAMH Specialist in laboratory medicine, main fields medical microbiology, immunology Diana Ciardo Head of Specialty laboratories
Head of Specialty laboratories T +41 61 486 14 45
MSc Infection Biology Siro Ellenberger Candidate FAMH Specialist in laboratory medicine, main field immunology
Candidate FAMH Specialist in laboratory medicine, main field immunology T +41 61 486 14 23
PhD Maurus Curti FAMH Specialist in laboratory medicine
FAMH Specialist in laboratory medicine T +41 61 486 14 75
Dr. sc. nat. Corinne Ruppen FAMH Specialist in laboratory medicine, main field clinical chemistry
FAMH Specialist in laboratory medicine, main field clinical chemistry T +41 61 486 13 67